Electron Microscopy of Central Dopamine Systems
Virginia M. Pickel1 and Susan R. Sesack2
1411 East 69th Street, KB 410
Department of Neurology and Neuroscience
Cornell University Medical College
New York, New York 10021
Phone: (212) 570-2900
Fax: (212) 988-3672
E-Mail: vpickel@mail.med.cornell.edu
2Department of Neuroscience
University of Pittsburgh
Pittsburgh, Pennsylvania 15260
REFERENCES
1.
Adams JC, Mugnaini E. Immunocytochemical evidence for inhibitory and
disinhibitory circuits in the superior olive.
Hear Res 1990;49:281-298.
2. Albin RL. The
functional anatomy of the basal ganglia disorders. TINS 1989;12:366-375.
3. Amalric M, Koob
GF. Functionally selective neurochemical afferents and efferents of the mesocorticolimbic
and nigrostriatal dopamine system. [Review]. Prog
Brain Res 1993;99:209-226.
4. Arai R, Kojima
Y, Geffard M, Kitahama K, Maeda T. Combined use of silver staining of the
retrograde tracer WGAapoHRP-Au and pre-embedding immunocytochemistry for electron
microscopy: Demonstration of dopaminergic terminals in synaptic contact with
striatal neurons projecting to the substantia nigra in the rat. J Histochem
Cytochem 1992;40:889-892.
5. Asan E. Ultrastructural
features of tyrosine-hydroxylase-immunoreactive afferents and their targets
in the rat amygdala. Cell Tissue Res 1997;288:449-469.
6. Asanuma M, Hirata
H, Cadet JL. Attenuation of 6-hydroxydopamine-induced dopaminergic nigrostriatal
lesions in superoxide dismutase transgenic mice. Neurosci
1998;85:907-917.
7.
Aubry J-M, Schulz M-F, Pagliusi S, Schulz P, Kiss JZ. Coexpression
of dopamine D2 and substance P (neurokinin- 1) receptor messenger
RNAs by a subpopulation of cholinergic neurons in the rat striatum.
Neurosci 1993;53:417-424.
8.
Bachelet CM, Scarcériaux V, Rostčne W, Pélaprat D. Evidence for neurotensin
autoreceptors and relationship of neurotensin and its receptors with tyrosine
hydroxylase-positive neurons in rat primary hypothalamic cultures.
Eur J Neurosci 1997;9:1483-1487.
9.
Bal A, Bachelot T, Savasta M, Manier M, Verna JM, Benabid AL, Feuerstein
C. Evidence for dopamine D2 receptor mRNA expression by striatal
astrocytes in culture: In situ hybridization and polymerase chain reaction
studies. Mol Brain Res 1994;23:204-212.
10.
Bayer VE, Pickel VM. GABA-labeled terminals form proportionally more
synapses with dopaminergic neurons containing low densities of tyrosine hydroxylase-immunoreactivity
in rat ventral tegmental area. Brain Res 1991;559:44-55.
11.
Bayer VE, Towle AC, Pickel VM. Ultrastructural localization of neurotensin-like
immunoreactivity within dense core vesicles in perikarya, but not terminals,
colocalizing tyrosine hydroxylase in the rat ventral tegmental area. J Comp Neurol 1991a;311:179-196.
12.
Bayer VE, Towle AC, Pickel VM. Vesicular and cytoplasmic localization
of neurotensin-like immunoreactivity (NTLI) in neurons postsynaptic to terminals
containing NTLI and/or tyrosine hydroxylase in the rat central nucleus of
the amygdala. J Neurosci
Res 1991b;30:398-413.
13a. Bergson C, Mrzljak L, Smiley JF, Pappy M, Levenson
R, Goldman-Rakic PS. Regional, cellular, and subcellular variations in the
distribution of D1 and D2 dopamine receptors in primate
brain. J Neurosci 1995;15:7821-7836.
13b. Biederman B, Frolich E, Grosche J, Wagner HJ,
Reichenbach A. Mammalian Muller (glial) cells express functional D2 dopamine
receptors. Neuroreport 1995;6:609-612.
14.
Bjelke B, Goldstein M, Tinner B, Andersson C, Sesack SR, Steinbusch
HW, Lew JY, He X, Watson S, Tengroth B, Fuxe K. Dopaminergic transmission
in the rat retina: evidence for volume transmission.
J Chem Neuroanat 1996;12:37-50.
15.
Bjorklund A, Lindvall O. Dopamine-containing systems in the CNS. In:
Bjorklund A, Hokfelt T, eds. Handbook of Chemical Neuroanatomy. Vol 2 Classical
Transmitters in the CNS, Part I. Amsterdam: Elsevier Science Publishers, 1984:55-121.
16.
Bolam JP, Francis CM, Henderson Z. Cholinergic input to dopaminergic
neurons in the substantia nigra: A double immunocytochemical study. Neurosci
1991;41:483-494.
17.
Bolam JP, Smith Y. The GABA and substance P input to dopaminergic neurones
in the substantia nigra of the rat. Brain Res 1990;529:57-78.
18.
Cadet JL, Brannock C. Free radicals and the pathobiology of brain dopamine
systems. Neurochem
Internat 1998;32:117-131.
19.
Carr DB, Sesack SR. Callosal terminals in the rat prefrontal cortex:
Synaptic targets and association with GABA-immunoreactive structures.
Synapse 1998;29:193-205.
20.
Cepeda C, Levine MS. Dopamine and N-methyl-D-aspartate receptor interactions
in the neostriatum. Dev.Neurosci. 1998;20:1-18.
21.
Charara A, Smith Y, Parent A. Glutamatergic inputs from the pedunculopontine
nucleus to midbrain dopaminergic neurons in primates: Phaseolus
vulgaris- leucoagglutinin anterograde labeling combined with postembedding
glutamate and GABA immunohistochemistry.
J Comp Neurol 1996;364:254-266.
22.
Chéramy A, Godeheu G, L'hirondel M, Glowinski J. Cooperative contributions
of cholinergic and NMDA receptors in the presynaptic control of dopamine release
from synaptosomes of the rat striatum. J
Pharmacol Exp Ther 1996;276:616-625.
23.
Delle Donne KT, Sesack SR, Pickel VM. Ultrastructural immunocytochemical
localization of the dopamine D2 receptor within GABAergic neurons
of the rat striatum. Brain
Res 1997;746:239-255.
24.
Descarries L, Watkins KC, Garcia S, Bosler O, Doucet G. Dual character,
asynaptic and synaptic, of the dopamine innervation in adult rat neostriatum:
A quantitative autoradiographic and immunocytochemical analysis. J Comp Neurol 1996;375:167-186.
25.
Deutch AY. Prefrontal cortical dopamine systems and the elaboration
of functional corticostriatal circuits: Implications for schizophrenia and
Parkinson's disease. J
Neural Transm 1993;91:197-221.
26.
Domesick VB, Stinus L, Paskevich PA. The cytology of dopaminergic and
nondopaminergic neurons in the substantia nigra and ventral tegmental area
of the rat: a light- and electron-microscopic study.
Neurosci 1983;8:743-765.
27.
Dumartin B, Caillé I, Gonon F, Bloch B. Internalization of D1 dopamine
receptor in striatal neurons in vivo as evidence of activation by dopamine
agonists. J Neurosci 1998;18:1650-1661.
28.
Fitzgerald LW, Deutch AY, Gasic G, Heinemann SF, Nestler EJ. Regulation
of cortical and subcortical glutamate receptor subunit expression by antipsychotic
drugs. J Neurosci 1995;15:2453-2461.
29.
Futami T, Hatanaka Y, Matsushita K, Furuya S. Expression of substance
P receptor in the substantia nigra. Mol Brain
Res 1998;54:183-198.
30.
Gábriel R, Zhu BS, Straznicky C. Tyrosine hydroxylase-immunoreactive
elements in the distal retina of Bufo marinus: a light and electron microscopic
study. Brain Res 1991;559:225-232.
31.
Garcia-Segura LM, Luquín S, Párducz A, Naftolin F. Gonadal hormone
regulation of glial fibrillary acidic protein immunoreactivity and glial ultrastructure
in the rat neuroendocrine hypothalamus. Glia 1994;10:59-69.
32.
Gauchy C, Desban M, Glowinski J, Kemel ML. Distinct regulations by
septide and the neurokinin-1 tachykinin receptor agonist [Pro9]substance
P of the N-methyl-D- aspartate-evoked
release of dopamine in striosome- and matrix- enriched areas of the rat striatum.
Neurosci 1996;73:929-939.
33.
Goldman-Rakic PS. The cortical dopamine system: role in memory and
cognition. Adv Pharmacol 1998;42:707-711.
34.
Goldman-Rakic PS, Leranth C, Williams SM, Mons N, Geffard M. Dopamine
synaptic complex with pyramidal neurons in primate cerebral cortex. Proc Natl Acad Sci USA. 1989;86:9015-9019.
35.
Haavik J, Toska K. Tyrosine hydroxylase and Parkinson's disease.
Mol Neurobio 1998;16:285-309.
36.
Harsing LG, Jr., Zigmond MJ. Postsynaptic integration of cholinergic
and dopaminergic signals on medium-sized GABAergic projection neurons in the
neostriatum. Brain
Res Bul 1998;45:607-613.
37.
Hersch SM, Ciliax BJ, Gutekunst C-A, Rees HD, Heilman CJ, Yung KKL,
Bolam JP, Ince E, Yi H, Levey AI. Electron microscopic analysis of D1 and
D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships
with motor corticostriatal afferents. J Neurosci 1995;15:5222-5237.
38.
Hersch SM, Yi H, Heilman CJ, Edwards RH, Levey AI. Subcellular localization
and molecular topology of the dopamine transporter in the striatum and substantia
nigra. J Comp Neurol 1997;388:211-227.
39.
Hokoc JN, Mariani AP. Tyrosine hydroxylase immunoreactivity in the
rhesus monkey retina reveals synapses from bipolar cells to dopaminergic amacrine
cells. J Neurosci 1987;7:2785-2793.
40.
Horvath TL, Naftolin F, Leranth C. Luteinizing hormone-releasing hormone
and gamma-aminobutyric acid neurons in the medial preoptic area are synaptic
targets of dopamine axons originating in anterior periventricular areas.
J Neuroendocrinol 1993;5:71-79.
41.
Hösli E, Hösli L. Autoradiographic studies on the uptake of 3H-dopamine
by neurons and astrocytes in explant and primary cultures of rat CNS: Effects
of uptake inhibitors. Int
J Dev Neurosci 1997;15:45-53.
42.
Hrabovszky E, Liposits Z. Galanin-containing axons synapse on tyrosine
hydroxylase- immunoreactive neurons in the hypothalamic arcuate nucleus of
the rat. Brain
Res 1994;652:49-55.
43.
Huang Q, Zhou D, Chase K, Gusella JF, Aronin N, DiFiglia M. Immunohistochemical
localization of the D1 dopamine receptor in rat brain reveals its
axonal transport, pre- and postsynaptic localization, and prevalence in the
basal ganglia, limbic system, and thalamic reticular nucleus.
Proc Natl Acad Sci USA 1992;89:11988-11992.
44.
Ingham CA, Hood SH, Taggart P, Arbuthnott GW. Plasticity of synapses
in the rat neostriatum after unilateral lesion of the nigrostriatal dopaminergic
pathway. J Neurosci 1998;18:4732-4743.
45.
Jenner P. Oxidative stress as a cause of Parkinson's disease.
Acta Neurol Scand Suppl 1991;136:6-15.
46.
Kennedy MB. The postsynaptic density at glutamatergic synapses. TINS 1997;20:264-268.
47.
Keys AS, Mark GP. D1 and D2 dopamine receptor
mediation of amphetamine-induced acetylcholine release in nucleus accumbens.
Neurosci 1998;86:521-531.
48.
Kiss J, Halasz B. Synaptic connections between serotoninergic axon
terminals and tyrosine hydroxylase-immunoreactive neurons in the arcuate nucleus
of the rat hypothalamus. A combination of electron microscopic autoradiography
and immunocytochemistry. Brain
Res 1986;364:284-294.
49. Kolb H, Cuenca
N, Wang HH, Dekorver L. The synaptic organization of the dopaminergic amacrine
cell in the cat retina. J Neurocytol 1990;19:343-366.
50. Krieger NR, Megill
JR, Sterling P. Granule cells in the rat olfactory tubercle accumulate 3H-gamma-aminobutyric
acid. J Comp Neurol 1983;215:465-471.
51. Kuchel GA, Zigmond
RE. Functional recovery and collateral neuronal sprouting examined in young
and aged rats following a partial neural lesion. Brain
Res 1991;540:195-203.
52. Kuhar MJ. Recent
biochemical studies of the dopamine transporter - A CNS drug target. Life
Sci 1998;62:1573-1575.
53. Lamont EW, Kokkinidis
L. Infusion of the dopamine D1 receptor antagonist SCH 23390 into
the amygdala blocks fear expression in a potentiated startle paradigm.
Brain Res 1998;795:128-136.
54a. Lee T, Kaneko T,
Taki K, Mizuno N. Preprodynorphin-, preproenkephalin-, and preprotachykinin-
expressing neurons in the rat neostriatum: An analysis by immunocytochemistry
and retrograde tracing. J Comp Neurol 1997;386:229-244.
54b. Le Moine C, Bloch
B (1995) D1 and D2 dopamine receptor gene expression in the rat striatum:
sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs
in distinct neuronal populations of the dorsal and ventral striatum. J Comp Neurol 1995;355:418-426.
55. Levine MS, Cepeda
C. Dopamine modulation of responses mediated by excitatory amino acids in
the neostriatum. Adv Pharmacol 1998;42:724-729.
56. Lewis DA, Sesack
SR. Dopamine systems in the primate brain. In: Bloom FE, Bjorklund A, Hokfelt
T, eds. Handbood of Chemical Neuroanatomy. Amsterdam: Elsevier Science Publishers,
1997:261-373.
57. Marcos P, Corio
M, Dubourg P, Tramu G. Reciprocal synaptic connections between neurotensin-
and tyrosine hydroxylase-immunoreactive neurons in the mediobasal hypothalamus
of the guinea pig. Brain Res 1996;715:63-70.
58. Mena MA, Casarejos
MJ, Carazo A, Paino CL, De Yébenes JG. Glia conditioned medium protects fetal
rat midbrain neurones in culture from L-DOPA toxicity. Neuroreport
1996;7:441-445.
59. Mrzljak L, Bergson
C, Pappy M, Huff R, Levenson R, Goldman-Rakic PS. Localization of dopamine
D4 receptors in GABAergic neurons of the primate brain. Nature 1996;381:245-248.
60. Nakamura Y, Kubo
H, Kataoka K. Uptake of transmitter amino acids by glial plasmalemmal vesicles
from different regions of rat central nervous system. Neurochem Res 1994;19:1145-1150.
61. Nikolaus S, Huston
JP, Körber B, Thiel C, Schwarting RKW. Pretreatment with neurokinin substance
P but not with cholecystokinin-8S can alleviate functional deficits of partial
nigrostriatal 6-hydroxydopamine lesion. Peptides 1997;18:1161-1168.
62. Nirenberg MJ, Chan
J, Liu YJ, Edwards RH, Pickel VM. Ultrastructural localization of the vesicular
monoamine transporter-2 in midbrain dopaminergic neurons: Potential sites
for somatodendritic storage and release of dopamine. J Neurosci
1996;16:4135-4145.
63. Nirenberg MJ, Chan
J, Pohorille A, Vaughan RA, Uhl GR, Kuhar MJ, Pickel VM. The dopamine transporter:
Comparative ultrastructure of dopaminergic axons in limbic and motor compartments
of the nucleus accumbens. J
Neurosci 1997;17:6899-6907.
64. Nirenberg MJ, Pickel
VM. The vesicular and plasmalemmal dopamine transporters: ultrastructural
localization in nigrostriatal dopaminergic neurons. In: AnonymousProceedings
of the NATO Advanced Research Workshop on Neurotransmitter Release and Uptake.
Springer-Verlang, 1997:
65. Nirenberg MJ, Vaughan
RA, Uhl GR, Kuhar MJ, Pickel VM. The dopamine transporter is localized to
dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons.
J Neurosci 1996;16:436-447.
66. Okamura H, Kitahama
K, Nagatsu I, Geffard M. Comparative topography of dopamine- and tyrosine
hydroxylase- immunoreactive neurons in the rat arcuate nucleus. Neurosci
Lett 1988;95:347-353.
67. Pereda A, Triller
A, Korn H, Faber DS. Dopamine enhances both electrotonic coupling and chemical
excitatory postsynaptic potentials at mixed synapses. Proc
Natl Acad Sci USA 1992;89:12088-12092.
68. Peter D, Liu YJ,
Sternini C, De Giorgio R, Brecha N, Edwards RH. Differential expression of
two vesicular monoamine transporters. J Neurosci 1995;15:6179-6188.
69. Peters A, Palay
SL, Webster Hd. The Fine Structure of the Nervous System. 3 Ed. New York: Oxford University Press, 1991:1-494.
70. Pickel VM, Chan
J. Spiny neurons lacking choline acetyltransferase immunoreactivity are major
targets of cholinergic and catecholaminergic terminals in rat striatum. J Neurosci
Res 1990;25:263-280.
71. Pickel VM, Chan
J. Electron microscopic immunocytochemical labelling of endogenous and/or
transported antigens in rat brain using silver-intensified one-nanometer colloidal
gold. In: Cuello AC, ed. Immunohistochemistry II. IBRO: John Wiley and Sons,
1993:265-280.
72. Pickel VM, Chan
J, Sesack SR. Cellular basis for interactions between catecholaminergic afferents
and neurons containing Leu-enkephalin-like immunoreactivity in rat caudate-putamen
nuclei. J Neurosci Res 1992;31:212-230.
73. Pickel VM, Chan
J, Sesack SR. Cellular substrates for interactions between dynorphin terminals
and dopamine dendrites in rat ventral tegmental area and substantia nigra. Brain
Res 1993;602:275-289.
74. Pickel VM, Joh
TH, Chan J. Substance P in the rat nucleus accumbens: ultrastructural localization
in axon terminals and their relation to dopaminergic afferents.
Brain Res 1988;444:247-264.
75. Pickel VM, Johnson
E, Carson M, Chan J. Ultrastructure of spared dopamine terminals in caudate-putamen
nuclei of adult rats neonatally treated with intranigral 6- hydroxydopamine.
Dev Brain Res 1992;70:75-86.
76. Pickel VM, Milner
TA. Electron microscopy of central catecholamine systems. In: Meltzer HY,
ed. Psychopharmacology: The Third Generation of Progress. 1 Ed. New York: Raven Press, 1987:49-59.
77. Pickel VM, Nirenberg
MJ, Milner TA. Ultrastructural view of central catecholaminergic transmission:
immunocytochemical localization of synthesizing enzymes, transporters and
receptors. J Neurocytol 1997;25:843-856.
78. Pickel VM, Towle
AC, Joh TH, Chan J. γ-aminobutric
acid in the medial rat nucleus accumbens: ultrastructural localization in
neurons receiving monosynaptic input from catecholaminergic afferents. J
Comp Neurol 1988;272:1-14.
79. Radnikow G, Misgeld
U. Dopamine D1 receptors facilitate GABAA synaptic currents
in the rat substantia nigra pars reticulata. J Neuroscience 1998;18:2009-2016.
80. Rall W. Distinguishing
theoretical synaptic potentials computed for different soma-dendritic distributions
of synaptic input. J Neurophys 1966;30:1138-1168.
81. Revay R, Vaughan
R, Grant S, Kuhar MJ. Dopamine transporter immunohistochemistry in median
eminence, amygdala, and other areas of the rat brain. Synapse 1996;22:93-99.
82. Rodríguez JJ, Pickel
VM. Enhancement of N-Methyl-D-Aspartate (NMDA) immunoreactivity in residual
dendritic spines in the caudate-putamen nucleus after chronic haloperidol
administration. Synapse 1998;(submitted):
83. Scarnati E, Florio
T. The pedunculopontine nucleus and related structures - Functional organization. Adv Neurol 1997;74:97-110.
84. Schulinder S. A
molecular glimpse of vesicular monoamine transporters. J Neurochem 1994;62:2067-2078.
85. Seguela P, Watkins
KC, Descarries L. Ultrastructural features of dopamine axon terminals in the
anteromedial and the suprarhinal cortex of adult rat. Brain
Res 1988;442:11-22.
86. Sesack SR, Aoki
C, Pickel VM. Ultrastructural localization of D2 receptor-like
immunoreactivity in midbrain dopamine neurons and their striatal targets. J
Neurosci 1994;14:88-106.
87. Sesack SR, Hawrylak
VA, Matus C, Guido MA, Levey AI. Dopamine axon varicosities in the prelimbic
division of the rat prefrontal cortex exhibit sparse immunoreactivity for
the dopamine transporter. J Neurosci 1998;18:2697-2708.
88. Sesack SR, Pickel
VM. Dual ultrastructural localization of enkephalin and tyrosine hydroxylase
immunoreactivity in the rat ventral tegmental area: multiple substrates for
opiate-dopamine interactions. J
Neurosci 1992a;12:1335-1350.
89. Sesack SR, Pickel
VM. Prefrontal cortical efferents in the rat synapse on unlabeled neuronal
targets of catecholamine terminals in the nucleus accumbens septi and on dopamine
neurons in the ventral tegmental area. J Comp Neurol 1992b;320:145-160.
90. Sesack SR, Pickel
VM. Ultrastructural relationships between terminals immunoreactive for enkephalin,
GABA, or both transmitters in the rat ventral tegmental area. Brain
Res 1995;672:261-275.
91. Sesack SR, Snyder
CL, Lewis DA. Axon terminals immunolabeled for dopamine or tyrosine hydroxylase
synapse on GABA-immunoreactive dendrites in rat and monkey cortex.
J Comp Neurol 1995;363:264-280.
92. Smiley JF, Goldman-Rakic
PS. Heterogeneous targets of dopamine synapses in monkey prefrontal cortex
demonstrated by serial section electron microscopy: A laminar analysis using
the silver-enhanced diaminobenzidine sulfide (SEDS) immunolabeling technique.
Cereb Cortex 1993;3:223-238.
93. Smith Y, Bolam
JP. The output neurones and the dopaminergic neurones of the substantia nigra
receive a GABA-containing input from the globus pallidus in the rat. J Comp
Neurol 1990;296:47-64.
94. Smith Y, Charara
A, Parent A. Synaptic innervation of midbrain dopaminergic neurons by glutamate-enriched
terminals in the squirrel monkey. J Comp Neurol 1996;364:231-253.
95. Steffensen SC,
Svingos AL, Pickel VM, Henriksen SJ. Electrophysiological characterization
of GABAergic neurons in the ventral tegmental area. J Neurosci 1998;18:8003-8015.
96. Steinbusch HWM,
Tilders FJH. Immunohistochemical techniques for light microscopical localization
of dopamine, noradrenaline, adrenaline, serotonin and histamine in the central
nervous system. In: Steinbusch HWM, ed. Monoaminergic Neurons: Light Microscopy
and Ultrastructure. New York: John Wiley and Sons, 1993:125-166.
97. Stork O, Hashimoto
T, Obata K. Increase of tyrosine hydroxylase and its mRNA in the rat substantia
nigra pars reticulata by diazepam and picrotoxin. Neurosci
Res 1994;19:73-80.
98a. Sullivan AM, Opacka-Juffry
J, Blunt SB. Long-term protection of the rat nigrostriatal dopaminergic system
by glial cell line-derived neurotrophic factor against 6-hydroxydopamine in
vivo. Eur J
Neurosci 1998;10:57-63.
98b. Sulzer D, Joyce
MP, Lin L, Geldwert D, Haber SN, Hattori T, Rayport S. Dopamine neurons make
glutamatergic synapses in vitro. J Neurosci
1998;18:4588‑4602.
99. Surmeier DJ, Song
WJ, Yan Z. Coordinated expression of dopamine receptors in neostriatal medium
spiny neurons. J Neurosci 1996;16:6579-6591.
100. Svingos AL, Moriwaki
A, Wang JB, Uhl GR, Pickel VM. μ-Opioid receptors are localized to extrasynaptic plasma membranes
of GABAergic neurons and their targets in the rat nucleus accumbens.
J Neurosci 1997;17:2585-2594.
101. Taber MT, Das S,
Fibiger HC. Cortical regulation of subcortical dopamine release: Mediation
via the ventral tegmental area. J Neurochem 1995;65:1407-1410.
102. Takakusaki K, Shiroyama T, Kitai ST. Two types
of cholinergic neurons in the rat tegmental pedunculopontine nucleus: Electrophysiological
and morphological characterization. Neuroscience 1997;79:1089-1109.
103. Tamminga CA. Schizophrenia and glutamatergic
transmission. Crit Rev Neurobiol 1998;12:21-36.
104. Thind KK, Goldsmith
PC. Corticotropin-releasing factor neurons innervate dopamine neurons in the
periventricular hypothalamus of juvenile macaques. Synaptic evidence for a
possible companion neurotransmitter. Neuroendocrinology 1989;50:351-358.
105. Van Bockstaele EJ,
Gracy KN, Pickel VM. Dynorphin-immunoreactive neurons in the rat nucleus accumbens:
Ultrastructure and synaptic input from terminals containing substance P and/or
dynorphin. J Comp Neurol 1995;351:117-133.
106. Van Bockstaele EJ,
Sesack SR, Pickel VM. Dynorphin-immunoreactive terminals in the rat nucleus
accumbens: Cellular sites for modulation of target neurons and interactions
with catecholamine afferents. J Comp Neurol 1994;341:1-15.
107. Van den Pol AN.
Tyrosine hydroxylase immunoreactive neurons throughout the hypothalamus receive
glutamate decarboxylase immunoreactive synapses: a double pre-embedding immunocytochemical
study with particulate silver and HRP. J Neurosci 1986;6:877-891.
108. Van den Pol AN,
Herbst RS, Powell JF. Tyrosine hydroxylase-immunoreactive neurons of the hypothalamus:
A light and electron microscopic study. Neuroscience 1993;13:1117-1156.
109. Wang H, Moriwaki
A, Wang JB, Uhl GR, Pickel VM. Ultrastructural immunocytochemical localization
of m-opioid receptors in dendritic targets
of dopaminergic terminals in the rat caudate-putamen nucleus.
Neuroscience 1997;81:757-771.
110. Witkovsky P, Schutte M. The organization of
dopaminergic neurons in vertebrate retinas.
Vis Neurosci 1991;7:113-124.
111. Yazulla S, Zucker
CL. Synaptic organization of dopaminergic interplexiform cells in the goldfish
retina. Vis Neurosci 1988;1:13-29.
112. Young JK, McKenzie
JC, Baker JH. Association of iron-containing astrocytes with dopaminergic
neurons of the arcuate nucleus. J
Neurosci Res 1990;25:204-213.
113. Yung KKL, Bolam
JP, Smith AD, Hersch SM, Ciliax BJ, Levey AI. Immunocytochemical localization
of D1 and D2 dopamine receptors in the basal ganglia
of the rat: Light and electron microscopy.
Neuroscience 1995;65:709-730.
114. Yung KKL, Smith
AD, Levey AI, Bolam JP. Synaptic connections between spiny neurons of the
direct and indirect pathways in the neostriatum of the rat: Evidence from
dopamine receptor and neuropeptide immunostaining. Eur J Neurosci 1996;8:861-869.
115. Zahm DS. An electron
microscopic morphometric comparison of tyrosine hydroxylase immunoreactive
innervation of the neostriatum and the nucleus accumbens core and shell. Brain
Res 1992;575:341-346.
116. Zoli M, Torri C,
Ferrari R, Jansson A, Zini I, Fuxe K, Agnati LF. The emergence of the volume
transmission concept. Brain Res Rev 1998;26:136-147.
published 2000